Shanghai-based United Imaging Healthcare (UIH) has completed an initial public offering (IPO) of 100 million shares on the Shanghai Stock Exchange’s Sci-Tech Innovation Board (STAR). The listing raised RMB12.48 billion (USD1.85 billion) for the firm, bringing its post-listing market capitalization to around RMB100 billion.
Company Background
Founded in 2011, UIH focuses on the research and development of cutting-edge innovative medical imaging and radiotherapy products. The company has launched over 80 products, including magnetic resonance imaging (MRI) systems, x-ray computed tomography (CT) scanners, molecular imaging systems (PET-CT, PET-MRI), and others. UIH is also involved in life science instruments, medical robots, smart wearable devices, medical artificial intelligence, chips, third-party precision medical imaging diagnosis, and more.
R&D and Global Presence
According to UIH’s website, approximately 40% of the company’s 6,400 employees are engaged in R&D work. The company has R&D centers in China, the US, and other regions, generating over 2,600 patents, including more than 1,000 international patents. UIH’s investors include SDIC Fund Management, CICC, CITIC Securities, GJTA Investment, and others.-Fineline Info & Tech
